Redefining treatment options in chronic hand eczema (CHE).
Bissonnette
Robert
R
Innovaderm Research, Montreal, QC, Canada.
Diepgen
Thomas L
TL
Elsner
Peter
P
English
John
J
Graham-Brown
Robin
R
Homey
Bernhard
B
Luger
Thomas
T
Lynde
Charles
C
Maares
Jürgen
J
Maibach
Howard I
HI
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000077556:Alitretinoin; D002908:Chronic Disease; D004485:Eczema / Q000175:diagnosis / Q000628:therapy*; D019317:Evidence-Based Medicine; D005260:Female; D005500:Follow-Up Studies; D006229:Hand Dermatoses / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D012176:Retinoids / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014212:Tretinoin / Q000627:therapeutic use*; D055815:Young Adult
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D012176:Retinoids; D000077556:Alitretinoin; D014212:Tretinoin